Zenith Contract Services

ImmunoGen Reports Recent Progress and Third Quarter 2022 Financial Results

Retrieved on: 
Friday, November 4, 2022
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, Society, Bevacizumab, Ovarian cancer, FDA, PIN, Zenith Contract Services, Research, ImmunoGen, U.S. Securities and Exchange Commission, Clinical trial, Lilly, Oncology, Capital expenditure, National Comprehensive Cancer Network, Society of Gynecologic Oncology, Program, ESGO, Venetoclax, Company, Congress, BLA, Carboplatin, ASH, Gynecologic Oncology (journal), BPDCN, Journal of the National Comprehensive Cancer Network, PDUFA, Hematology-Oncology and Stem Cell Transplantation Research Center, Security (finance), IMGN, Control, Patient, Cancer, ADC, Maintenance, Azacitidine, ESMO, European Society of Gynaecological Oncology, COVID-19, Annual general meeting, Novartis, SOHO, NCCN, SGO, Acute myeloid leukemia, Standard of care, Risk, AML, György Enyedi (geographer), Vaccine, Pharmaceutical industry, Medical imaging, Platinum, Cryptocurrency

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in the business and reported financial results for the quarter ended September 30, 2022.

Key Points: 
  • ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in the business and reported financial results for the quarter ended September 30, 2022.
  • With an intense focus on execution, we are well positioned to transform ImmunoGen into a fully-integrated oncology company this year.
  • Total revenues were $15.4 million for the quarter ended September 30, 2022 compared to $9.2 million for the quarter ended September 30, 2021.
  • Operating expenses for the quarter ended September 30, 2022 were $92.8 million, compared with $43.4 million for the same quarter in 2021.

LincLogistics Rebrands to OptiX

Retrieved on: 
Monday, October 31, 2022
Manufacturing, Maritime, Logistics, Supply Chain Management, Transport, Chemicals, Plastics, Safety, Intermodal transport, Multimedia, Compliance, Gulf Coast of the United States, Partnership, Solution, Port of Savannah, Zenith Contract Services, Investment, OptiX, Transport, LLC, Intermodal freight transport, Warehouse

LincLogistics LLC, one of the fastest growing intermodal logistics services providers in the US, announced today it has rebranded to OptiX LLC (OptiX).

Key Points: 
  • LincLogistics LLC, one of the fastest growing intermodal logistics services providers in the US, announced today it has rebranded to OptiX LLC (OptiX).
  • Providing relevant solutions to our customers issues has been our intentional focus since inception, says Adam Borden, President of OptiX.
  • Lilium Group has been proud to support LincLogistics since inception, and we are excited to grow our investment to allow OptiX to diversify and expand its service offerings, said Peterson Hawkins, Partner at Lilium Group and Executive Chairman of OptiX.
  • OptiX LLC (OptiX) is a leading intermodal logistics services provider focused on both dedicated contract services as well as traditional import/export drayage and related services including storage and 3PL solutions.

J.B. Hunt Celebrates Second Driver in Company History to Achieve Five Million Safe Driving Miles

Retrieved on: 
Tuesday, October 25, 2022
Other Transport, Trucking, Rail, Logistics, Supply Chain Management, Transport, Culture, Efficiency, Achievement, Professional, JBHT, Family, NASDAQ, J. B. Hunt, Multimedia, Dow Jones, History, Industry, Health, Zenith Contract Services, Transport, Safety, Celebration, Management, Entertainment, Haslet

View the full release here: https://www.businesswire.com/news/home/20221024005951/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221024005951/en/
    Tony Broussard, a J.B. Hunt Intermodal driver based in Haslet, Texas, recently became the second driver in company history to achieve five million safe driving miles.
  • (Photo: Business Wire)
    Tony Broussard, a J.B. Hunt Intermodal driver who started with the company in 1987, surpassed the career-defining milestone on October 21.
  • Hopefully, God willing and I'm in good health, seven years from now I'll get that next million [safe miles]."
  • Tony will receive a $50,000 bonus for his achievement, bringing his career total in Million Mile safe driving bonuses to $125,000.

Extendicare Announces October 2022 Dividend of C$0.04 per Share

Retrieved on: 
Monday, October 17, 2022
Population, Bed, TSX, Section 50C of the Isle of Man Income Tax Act 1970, Company, Health, Zenith Contract Services, GLOBE, Forward-looking statement, Disclosure, Income Tax Act, Retirement, Health insurance, Extendicare

MARKHAM, Ontario, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (Extendicare or the Company) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the Common Share) for the month of October 2022, which is payable on November 15, 2022 to shareholders of record at the close of business on October 31, 2022.

Key Points: 
  • MARKHAM, Ontario, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (Extendicare or the Company) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the Common Share) for the month of October 2022, which is payable on November 15, 2022 to shareholders of record at the close of business on October 31, 2022.
  • This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada).
  • Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.
  • Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicares website at www.extendicare.com.

Clinisys completes combination of Sunquest, HORIZON and ApolloLIMS businesses

Retrieved on: 
Wednesday, October 5, 2022
Water, Zenith Contract Services, Information, Apollo, Health care, Informatics, Public health, Laboratory, Private sector, Food, Health, African Crop Science Journal, Sunquest Information Systems, Foodservice, Belgium, Solution, List of life sciences, Pharmaceutical industry, Pharma

TUCSON, Ariz., Oct. 5, 2022 /PRNewswire/ -- Clinisys today announces it has completed the combination of Sunquest Information Systems, HORIZON Lab Systems, and Apollo LIMS under its singular brand.

Key Points: 
  • TUCSON, Ariz., Oct. 5, 2022 /PRNewswire/ -- Clinisys today announces it has completed the combination of Sunquest Information Systems, HORIZON Lab Systems, and Apollo LIMS under its singular brand.
  • The completion marks a new chapter for Clinisys, expanding its global presence and breadth of expertise to enable healthier communities through the transformation of the modern laboratory.
  • Clinisys is now one of the largest information systems providers for laboratories globally across healthcare, life sciences, and public health with over 3,000 customers in 34 countries.
  • For existing customers, the combination of the new businesses will not affect the existing products and services provided to them, which will now be delivered to them using the new Clinisys brand.

Clinisys completes combination of Sunquest, HORIZON and ApolloLIMS businesses

Retrieved on: 
Wednesday, October 5, 2022
Water, Zenith Contract Services, Information, Apollo, Health care, Informatics, Public health, Laboratory, Private sector, Food, Health, African Crop Science Journal, Sunquest Information Systems, Foodservice, Belgium, Solution, List of life sciences, Pharmaceutical industry, Pharma

TUCSON, Ariz., Oct. 5, 2022 /PRNewswire/ -- Clinisys today announces it has completed the combination of Sunquest Information Systems, HORIZON Lab Systems, and Apollo LIMS under its singular brand.

Key Points: 
  • TUCSON, Ariz., Oct. 5, 2022 /PRNewswire/ -- Clinisys today announces it has completed the combination of Sunquest Information Systems, HORIZON Lab Systems, and Apollo LIMS under its singular brand.
  • The completion marks a new chapter for Clinisys, expanding its global presence and breadth of expertise to enable healthier communities through the transformation of the modern laboratory.
  • Clinisys is now one of the largest information systems providers for laboratories globally across healthcare, life sciences, and public health with over 3,000 customers in 34 countries.
  • For existing customers, the combination of the new businesses will not affect the existing products and services provided to them, which will now be delivered to them using the new Clinisys brand.

ZOLL Selected to Exhibit TherOx SSO2 Therapy at Vizient Innovative Technology Exchange

Retrieved on: 
Monday, October 3, 2022
Cardiology, Data Management, Technology, Manufacturing, Other Health, Health, General Health, Other Technology, Medical Devices, Other Manufacturing, Hardware, Ventilation, Hospital, Asahi Kasei, Heart, Zenith Contract Services, Sleep apnea, Technology, Mohawk Innovative Technology, Exchange, FDA, Massachusetts Innovation & Technology Exchange, Death, LAD, EMS, Safety, Vizient, Inc., Heart failure, Diagnosis, Muscle tissue, Data management, CPR, Pharmaceutical industry, Medical device, STEMI

ZOLL, an Asahi Kasei company, has been selected to exhibit SuperSaturated Oxygen (SSO2) Therapy, which delivers high levels of dissolved oxygen directly to the heart following severe heart attack, at the Vizient Innovative Technology Exchange.

Key Points: 
  • ZOLL, an Asahi Kasei company, has been selected to exhibit SuperSaturated Oxygen (SSO2) Therapy, which delivers high levels of dissolved oxygen directly to the heart following severe heart attack, at the Vizient Innovative Technology Exchange.
  • Vizient, Inc , the nations largest member-driven health care performance improvement company, will hold the Exchange on October 17 in Dallas.
  • The Exchange is an exciting part of the Vizient Innovative Technology Program, which results in Innovative Technology contract awards for the qualified products.
  • The annual Innovative Technology Exchange is part of Vizients Innovative Technology Program that includes product review of supplier-submitted technologies by member-led councils and task forces.

IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation

Retrieved on: 
Wednesday, September 28, 2022
Technology, Security, Clinical Trials, Practice Management, Biotechnology, Networks, Managed Care, Health, Data Management, Government, Privacy, Trust, TrustArc, NYSE, IQV, Compliance, DCTS, Industry, Program, Patient, DCT, CEO, Technology, Head, Clinical trial, Zenith Contract Services, GDPR, SVP, ISO, Cryptocurrency, Medical device, IQVIA

IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc.

Key Points: 
  • IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc.
  • TRUSTArcs third-party validation demonstrates that IQVIAs DCT program processes personal data in accordance with GDPR, allowing customers to address participant and investigator privacy concerns that may arise because of their participation in decentralized trials.
  • IQVIA is proud to have this validation prove our longstanding dedication to data protection in decentralized trials.
  • TRUSTArc maps its GDPR Validation requirements to applicable GDPR Articles and ISO 27001 standards, alongside the standards of its own Privacy and Data Governance Accountability Framework.

American Water Charitable Foundation and American Water Military Services Group Partner with K9s For Warriors to Help Improve Veterans' Lives One Dog at a Time

Retrieved on: 
Thursday, September 15, 2022
Veterans, Pets, Utilities, Military, Philanthropy, Energy, Consumer, Foundation, Other Philanthropy, Defense, Diamond, People, Working dog, Scott Air Force Base, Joint Base Lewis–McChord, Hydro, Twitter, Wright-Patterson Air Force Base, NYSE, Policy, Fort A.P. Hill, Hill Air Force Base, Joint Base San Antonio, Community, Picatinny Arsenal, LinkedIn, Dog, Service, Partnership, American Water, Mental health, History, Water, Zenith Contract Services, Alachua, CEO, Military sexual trauma, Veteran, Vandenberg Space Force Base, Work, Foundation, K9s for Warriors, Assistance dog, Naval base, Multimedia, Awareness, Suicide, PTSD, Pharmaceutical industry, Hospital, Labrador Retriever, Phoenix, American, Facebook

Hydro is a one year old black Labrador Retriever, whose name was selected by American Water Military Services Group employees.

Key Points: 
  • Hydro is a one year old black Labrador Retriever, whose name was selected by American Water Military Services Group employees.
  • (Photo: Business Wire)
    The American Water Charitable Foundation is pleased to partner with K9s For Warriors to support our veterans and Service Dogs, said Carrie Williams, president, American Water Charitable Foundation.
  • We are delighted to partner with the American Water Charitable Foundation in selecting an organization that supports the veteran community and resonates with our team, said Steve Curtis, president, American Water Military Services Group and Contract Services Group.
  • American Water provides safe, clean, affordable and reliable water services to our customers to help keep their lives flowing.

Extendicare Announces September 2022 Dividend of C$0.04 per Share

Retrieved on: 
Thursday, September 15, 2022
Health, TSX, Bed, Company, Population, Forward-looking statement, Section 50C of the Isle of Man Income Tax Act 1970, Income Tax Act, Zenith Contract Services, Retirement, GLOBE, Disclosure, Health insurance, Extendicare

MARKHAM, Ontario, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (Extendicare or the Company) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the Common Share) for the month of September 2022, which is payable on October 17, 2022 to shareholders of record at the close of business on September 30, 2022.

Key Points: 
  • MARKHAM, Ontario, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (Extendicare or the Company) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the Common Share) for the month of September 2022, which is payable on October 17, 2022 to shareholders of record at the close of business on September 30, 2022.
  • This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada).
  • Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.
  • Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicares website at www.extendicare.com.